Ellevest Inc’s Vaxcyte PCVX Stock Holding History

Ellevest Inc’s Portfolio PCVX Stock Details PCVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-45	Closed	-$1.69K	–	1259
2023 Q1	$1.69K	Buy	45 +25	+125%	+$1.06K	﹤0.01%	1478
2022 Q4	$959	Buy	+20	New	+$785	﹤0.01%	1531

Other funds holding PCVX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Ellevest Inc's PCVX Position: Q2 2023 in Review

Ellevest Inc sold out of Vaxcyte (PCVX) in Q2 2023, closing a stake of 45 shares — an estimated $1.69K sold.

Ellevest Inc first reported a position in PCVX in Q4 2022 and held it in 2 quarters. The position peaked at $1.69K in Q1 2023. 197 funds tracked by Wall St. Rank hold PCVX as of Q2 2023.

Ellevest Inc reported no remaining Vaxcyte position as of Q2 2023 after selling out during the quarter.
Ellevest Inc sold 45 Vaxcyte shares in Q2 2023, an estimated $1.69K.
Ellevest Inc first reported a position in Vaxcyte in Q4 2022 and held it in 2 quarters.
Ellevest Inc's Vaxcyte position peaked at $1.69K in Q1 2023.
197 funds tracked by Wall St. Rank held Vaxcyte as of Q2 2023.

Based on Ellevest Inc's 13F filing for Q2 2023, filed 9 Aug 2023.